跳到主要內容

簡易檢索 / 詳目顯示

研究生: 羅綠楊
論文名稱: 百略醫學科技股份有限公司:國際品牌、品牌策略個案研究
指導教授: 白德傑
學位類別: 碩士
Master
系所名稱: 商學院 - 國際經營管理英語碩士學位學程(IMBA)
International MBA Program College of Commerce(IMBA)
論文出版年: 2008
畢業學年度: 96
語文別: 英文
論文頁數: 20
中文關鍵詞: 百略醫學科技股份有限公司
相關次數: 點閱:256下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 百略醫學科技股份有限公司:國際品牌、品牌策略個案研究


    Abstract

    Microlife Corporation: A Globalizing Brand
    By
    Gerald A. Roliz

    Microlife Corporation engages in the development and manufacturing of medical diagnostic equipment for institutional and home use worldwide. Their primary product offering includes blood pressure monitors, digital thermometers, and asthma monitors. All hardware products primarily reach end users through the retail channel, while pressure on contribution margins constantly grows due to increased competition.
    The product pipeline for Microlife Corporation is quite prolific and includes 2 product lines that are set for imminent launch and will be distributed to a new target market that is unfamiliar with the Microlife brand. The senior executives of Microlife Corporation Kin Yuan Lin, Ty-minh Tan, and Scot Muve must decide on how to proceed with the firm’s brand strategy development. The transfer of existing brand equity from the retail channel into the professional channel remains an issue and requires considerable discussion.
    Furthermore, the medical device industry is spawning new innovations, which leads to new developments of medical technologies. Earlier detection of diseases, digitalization of data, and secure transmission of information among healthcare professionals are developing trends.
    To keep up with the evolution of the medical device industry’s new medical technologies, Microlife Corporation acquired and created 2 new product lines. Both are in pre-launch phase and proven to successfully integrate medical hardware devices with functional software solutions. The Microlife Medical Home Solutions (MiMHS) subsidiary functions as the research arm for workflow solutions, software platforms, and patient positive outcome guidelines for physician clinics. The Microlife executives foresee healthcare systems in many countries will gradually shift toward pay-for-performance reimbursement systems. Both patients and tending physicians will be held more accountable for healthcare fees and reimbursement in the future.
    Microlife Corporation contracted Direction Design Group to assist in the remodeling of their existing Corporate Identity and to assist in brand strategy development for the future product offerings that will ensure Microlfe Corporation’s customers continue to recognize, understand, and believe in the Microlife brand.
    Microlife. A partner for people. For life.

    TABLE OF CONTENTS
    Abstract ………………………………………………………………………… iii
    Acknowledgements …………………………………………………………… v
    Table of Contents ……………………………………………………………… vi
    1. Story Introduction ……………………………………………………………. 1
    2. Company Background ..……………………………………………………… 2
    3. The Medical Device Industry ...……………………………………………… 2
    3.1 Industry Investment ……………………………………………………. 3
    3.2 Increasing Costs ……………………………………………………….. 4
    3.3 Reimbursement Challenges ……………………………………………. 4
    3.4 Technology Guided Evolution of Healthcare ………………………….. 5
    4. Third Generation Product Lines ……………………………………………... 6
    5. Advanced Medical Home ……………………………………………………. 7
    6. Meeting Break ……………………………………………………………….. 7
    7. The Current Microlife Corporate Brand …………………………………… 8
    7.1 Brand Management .………………………………………………….. 9
    7.2 Centralized control over Global Branding ……………………………. 10
    8. DDG | Direction Design Group LLC, Taiwan Branch ……………………… 10
    8.1 Physician feedback .…………………………………………………. 11
    9. The Next Step | WatchBP …………………………………………………… 12
    10. Discussion Questions ………………………………………………………... 14
    11. Exhibits ...………………………………………………………………….. 15
    12. Final Outcome ……………………………………………………………... 20

    none

    無法下載圖示 此全文未授權公開
    QR CODE
    :::